MODB | ZFIN | Morpholino Index | Advance Search | BLAST Search | About MODB
Search By For Use * as a wildcard character (e.g. "BMP*"). For Tips on search see Search FAQs.
Morpholino Summary
General Information
Morpholino name: SC5008-control    
Morpholino sequence: GATGTTTGGACGAGGACACGGTACT
Find in Genbank
Target name: sfrp2-control
Target sequence: (Morpholino Target and ATG)
Search in Genbank Search in Ensembl
GTAACCCACGGGCGCTCAACTGAAGTAAAGATGCGTGCCTATCTGGCTCTGCTGGTTGCGCTTTCCATC CCGGGATATCTGGATGCGCTTCACGGATTATACGCCTTCGATCAGCCTGAGCTCTTTCAGAAAAAGAGCA ACTGTAAGCCCATACCTACAAACCTGCTCCTGTGCCATGACATCGAGTACACAAACATGCGTCTGCCTAA CCTCCTCGGACACGAGACCATGAACGAGGTTCTGCAACAAGCATCCTCCTGGACCCCTCTGGTGCAGAAA CAGTGTCATCCGGACACCAAGAAGTTTCTCTGCTCTCTCTTCGCTCCGGTGTGTTTGGATGACCTGGACG AGCCCATCCAGCCGTGCAGGTCTCTGTGTGAGAGCGTGAAGAGCGGCTGCGCTCCGGTGATGGCCGCTTT TGGGTTCCCTTGGCCGGACATGCTGGACTGCAGGCGCTTCCCTTTAGATAATGACCTGTGCATACCGCCT GCTGGCGCTGATGCTTTAGTACCAGTCACTAAGGAAGTTCCAAGAGTATGTGATGCCTGCAAGGAAAAGC CTGAAAATGACAACGAAATTGTGGACAGCCTATGCAAAAATGACTTTGCTTTAAAGATCAAAGTCAAGGA GATCTCCTACATGAATGGTGACACCAAGATCATTCCAGAAACCAAGAGCAAGATGATCTACAAGACGAAT GGTGGCGTCACTGACCATGACTTTAGGAAGACGGTGCTTTGGCTAAAAGATGGTCTTCAGTGTGTGTGCG ATGAACTAAATGACATCAATGCTGCTTATTTGGTGATGGGCCAGAAGATGGATGGAAATTTGGTCATCAC ATCGGTGAAACGCTGGCAGAAGGGTCAACGAGAGTTTAAGAGAATTTCTCGCAGCATTCGCAAACTTCAG TGCTAGGATTTGTCAACTTGAATCACTAGAGTGCTCAAATGATCTTACAAAATGAACACCTGTAACAATC ACACTAGATACAGGAAGGTTTATTGAAGAGCCTTCTGTCTGCTTTACCAGTGCCATTATGAGAAATGAAT GGTCAGAGCTCAGGATTGAGAATGGTGGATCTTTCAAAAAGCACCTAGTATAGATTCAGCCTCACCAGTT AAGTTTTTCTTCATGAGTTTTACTTTATCTGTTATATTTACTACAAAACATATTGCTTATTTCTCTCCTT TAGGATAGTTAACTTTACAAAAAAAAAAAAAAAAAAAAAAA
Gene targeted:
not assigned
Synonyms:
Comments:
Reference:

Survival Curve: Normality Curve:
Note: When more than one data point existed per dose an average was used. p53 morpholino co-injections were used to minimize non-specific toxicity effects (Robu et al. PLoS Genetics 2007)
Screens Performed (number of tests): Defects Observed:
Blood: (7)
PAX2: (2)
Eye: (2)
- blood decreased
(83.33%, dose:4.5ng, p53:0ng, days: -)
- common cardinal vein [proposed pooling]
(83.33%, dose:4.5ng, p53:0ng, days: -)

Images